Midazolam + Atomoxetine Hydrochloride Interaction
Unknowninteraction on record
Description
CYP3A Substrate (e.g., Midazolam) — Coadministration of atomoxetine (60 mg BID for 12 days) with midazolam, a model compound for CYP3A4 metabolized drugs (single dose of 5 mg), resulted in 15% increase in AUC of midazolam.
Source: FDA drug label - atomoxetine hydrochloride